| 1 |
Uchida K, Shoda J, Sugahara S, et al. Comparison and survival of patients receiving hemodialysis and peritoneal dialysis in a single center [J]. Adv Perit Dial, 2007, 23: 144-149.
|
| 2 |
Eneman JD, Philips GK. Cancer management in patients with end-stage renal disease [J]. Oncology (Williston Park), 2005, 19(9): 1199-1212.
|
| 3 |
Capusa C, Stoian I, Rus E, et al. Does dialysis modality influence the oxidative stress of uremic patients? [J]. Kidney Blood Press Res, 2012, 35(4): 220-225.
|
| 4 |
Popolo A, Autore G, Pinto A, et al. Oxidative stress in patients with cardiovascular disease and chronic renal failure [J]. Free Radic Res, 2013, 47(5): 346-356.
|
| 5 |
Yavuz O, Bicik Z, Cinar Y, et al. The effect of different dialysis membranes on oxidative stress and selenium status [J]. Clin Chim Acta, 2004, 346(2): 153-160.
|
| 6 |
Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis [J]. Perit Dial Int, 2008, 28(3): 183-187.
|
| 7 |
Autore G, Marzocco S, Sorrentino R, et al. In vitro and in vivo TNFalpha synthesis modulation by methylguanidine, an uremic catabolyte [J]. Life Sci, 1999, 65(11): 121-127.
|
| 8 |
Ridão Curty NF, da Silva Martins LF, Sanches Ito CA, et al. Morbimortality study of infection in patients undergoing different types of dialysis in a renal replacement therapy center [J]. Braz J Infect Dis, 2014, 18(3): 281-286.
|
| 9 |
Hekmat R, Gholami F, Ahmadnia H, et al. Serum human T-lymphotropic virus 1 proviral load in patients on hemodialysis [J]. Iran J Kidney Dis, 2013, 7(2): 124-128.
|
| 10 |
Holley JL. Screening, diagnosis, and treatment of cancer in long-term dialysis patients [J]. Clin J Am Soc Nephrol, 2007, 2(3): 604-610.
|
| 11 |
Yamamoto T, Nakajima Y, Yamamoto M, et al. Epstein-Barr virus activity in patients on chronic hemodialysis [J]. Nephron, 1995, 70(4): 449-454.
|
| 12 |
Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS [J]. Kidney Int, 2004, 65(6): 2335-2342.
|
| 13 |
Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data [J]. Nephrol Dial Transplant, 2009, 24(5): 1598-1603.
|
| 14 |
Bugelski PJ, Volk A, Walker MR, et al. Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia [J]. Int J Toxicol, 2010, 29(5): 435-466.
|
| 15 |
Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study [J]. Arthritis Rheum,1995, 38(8): 1120-1127.
|
| 16 |
Vial T, Descotes J. Immunosuppressive drugs and cancer [J]. Toxicology, 2003, 185(3): 229-240.
|
| 17 |
Nagy A, Walter E, Zubakov D, et al. High risk of development of renal cell tumor in end-stage kidney disease: the role of microenvironment [J]. Tumour Biol, 2016, 37(7): 9511-9519.
|
| 18 |
Bonsib SM. Renal cystic diseases and renal neoplasms: a mini-review [J]. Clin J Am Soc Nephrol, 2009, 4(12): 1998-2007.
|
| 19 |
Denton MD, Magee CC, Ovuworie C, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis [J]. Kidney Int, 2002, 61(6): 2201-2209.
|
| 20 |
Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients [J]. Am J Kidney Dis, 2001, 38(6): 1343-1350.
|
| 21 |
Blaszczyk U, Duda-Chodak A. Magnesium: its role in nutrition and carcinogenesis [J]. Rocz Panstw Zakl Hig, 2013, 64(3): 165-171.
|
| 22 |
Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis [J]. J Inherit Metab Dis, 2011, 34(1): 101-109.
|
| 23 |
Mandayam S, Shahinian VB. Are chronic dialysis patients at increased risk for cancer? [J]. J Nephrol, 2008, 21(2): 166-174.
|
| 24 |
Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study [J]. Lancet, 1999, 354(9173): 93-99.
|
| 25 |
Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers [J]. Nature, 1998, 396(6712): 643-649.
|
| 26 |
Rao M, Li L, Demello C, et al. Mitochondrial DNA injury and mortality in hemodialysis patients [J]. J Am Soc Nephrol, 2009, 20(1): 189-196.
|
| 27 |
Sebekova K, Wagner Z, Schupp N, et al. Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute? [J]. Kidney Blood Press Res, 2007, 30(1): 56-66.
|
| 28 |
Lin MY, Kuo MC, Hung CC, et al. Association of dialysis with the risks of cancers [J]. PloS One, 2015, 10(4): e0122856.
|
| 29 |
Herman M, Ori Y, Chagnac A, et al. Spontaneous DNA repair increases during hemodialysis [J]. Nephron Clin Pract, 2008, 108(3): 188-193.
|
| 30 |
Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity [J]. Kidney Int, 1999, 56(1): 355-377.
|
| 31 |
Cambier JF, Ronco P. Onco-nephrology: glomerular diseases with cancer [J]. Clin J Am Soc Nephrol, 2012, 7(10): 1701-1712.
|
| 32 |
Magyarlaki T, Kiss B, Buzogany I, et al. Renal cell carcinoma and paraneoplastic IgA nephropathy [J]. Nephron, 1999, 82(2): 127-130.
|
| 33 |
Tatsis E, Reinhold-Keller E, Steindorf K, et al. Wegener′s granulomatosis associated with renal cell carcinoma [J]. Arthritis Rheum, 1999, 42(4): 751-756.
|
| 34 |
Bacchetta J, Juillard L, Cochat P, et al. Paraneoplastic glomerular diseases and malignancies [J]. Crit Rev Oncol Hematol, 2009, 70(1): 39-58.
|
| 35 |
Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin′s lymphoma: report of 21 cases and review of the literature [J]. Kidney Int, 2006, 69(12): 2251-2260.
|
| 36 |
Audard V, Zhang SY, Copie-Bergman C, et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes [J]. Blood, 2010, 115(18): 756-3762.
|
| 37 |
Heher EC, Rennke HG, Laubach JP, et al. Kidney disease and multiple myeloma [J]. Clin J Am Soc Nephrol, 2013, 8(11): 2007-2017.
|
| 38 |
Janus N, Launay-Vacher V, Thyss A, et al. Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study [J]. Ann Oncol, 2013, 24(2): 501-507.
|